HOME >> MEDICINE >> NEWS
7,000 Pharmaceutical scientists to share latest drug developments and discoveries

AAPS Annual Meeting Takes Place in New Orleans, November 14-18

ALEXANDRIA, Va.-- More than 7,000 pharmaceutical scientists will gather in New Orleans, November 14-18 at the 1999 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, The Quest for the Magic Bullet: An Outstanding Century. Scientists from around the world will share the latest developments in the field of pharmaceutical research and development.

"The AAPS Annual Meeting is the largest gathering of pharmaceutical scientists worldwide," said AAPS President Larry Augsburger, Ph.D. "Scientists at this meeting will present more than 2,500 contributed papers featuring important scientific findings."

The plenary session, "The Quest for the Magic Bullet: An Outstanding Century," takes place on Nov. 15, 8:30 a.m. - 12:00 p.m. The session will reflect on outstanding achievements in the pharmaceutical sciences during the 20th Century and examine how recent advances in research, development and technology will lead the pharmaceutical sciences into the next century.

"The plenary session promises to provide a glimpse into the future of drug therapy and health care and a recap of the most significant advances made in the pharmaceutical sciences over the past century," said AAPS Annual Meeting Program Chair Jay Sisco, Ph.D.

The meeting will offer nine short courses, 17 roundtables and 43 symposium sessions, which focus on topics such as the future of genetic immunization, recent developments in drug delivery and targeting, advances in vaccines, emerging analytical/bioanalytical techniques, particle engineering and modeling techniques, and competition in a patient-driven market.

Meeting highlights include:

  • 61623: Jane E. Henney, M.D., Commissioner of the Food and Drug Administration, will deliver the keynote address at the meeting's opening session on Nov. 14. Dr. Henney will outline her vision for the FDA as the agency ente
    '"/>


Contact: Amy Miller
miller@aaps.org
703--518-8417
American Association of Pharmaceutical Scientists
14-Jun-1999


Page: 1 2

Related medicine news :

1. Pharmaceutical marketing tactics hold little sway with prescribing physicians
2. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
3. Pharmaceutical Achievers
4. Pharmaceutical industry still failing health needs of less-developed countries
5. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
6. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
7. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
8. American Association of Pharmaceutical Scientists Dietary Supplements Forum examines science behind nutraceuticals
9. Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years
10. Pharmaceuticals and personal care products
11. New publisher announced for Journal Of Pharmaceutical Sciences

Post Your Comments:
(Date:4/2/2015)... Atlanta-based Kanga, the first SaaS-based platform ... Best Start Up in Atlanta by General Assembly Atlanta. ... Calend.ly, GottaGolf, LOV, Ticket Alternative, and TripTap. T General ... of over 500 at their Atlanta Launch Party at ... and mobile platform for initiating, managing and tracking last ...
(Date:4/1/2015)... April 01, 2015 In April, the ... endeavor to raise autism awareness by illuminating Richmond’s historic ... will be one of thousands of businesses, schools and ... using exterior lighting to brighten up the night sky ... spectrum. This collaborative effort is the 8th annual awareness ...
(Date:4/1/2015)... One year ago today, the USO cut the ribbon on ... States and changed the landscape on Naval Support Activity Bethesda ... more than 100,000 troops and military families in the last ... injured and their families, proving to be a valuable resource ... the country. After opening its doors on the campus that ...
(Date:4/1/2015)... 01, 2015 After a particularly harsh winter, ... potholes can lead to costly damage, so Amica Insurance ... is sharing the following suggestions from AAA: , ... and be inflated to the manufacturer’s recommended levels. , ... excessive vibration and uneven tire wear can be signs of ...
(Date:4/1/2015)... 01, 2015 It all began at home ... Gasbarro, who was on a mission to create a line ... ingredients that parents could trust. Now, Shoosha Truly Organic is ... skincare products, meaning all products contain a minimum 95% certified ... Babies’ skin is considered to be 40% thinner than adults ...
Breaking Medicine News(10 mins):Health News:Kanga Wins Best Start Up in Atlanta 2Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 2Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 3Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 4Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 5Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 3
(Date:4/1/2015)... 2015  The fairness of the proposed acquisition of ... Pharmaceutical Industries ("Teva") is being investigated by WeissLaw LLP, ... investigation focuses on possible breaches of fiduciary duty and ... of ASPX for agreeing to sell the Company to ... definitive agreement for Teva to acquire ASPX in a ...
(Date:4/1/2015)... , April 1, 2015  Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of an offering of $60.0 million aggregate principal ... (the "notes") in a private placement to qualified ... Securities Act of 1933, as amended (the "Act"). ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and Markets ... the "An Introduction to the Medical Device Directives" ... provides a detailed introduction to the European medical device ... are covered, the involvement of Notified Bodies, how to ... It will also cover the documentation necessary to apply ...
Breaking Medicine Technology:WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2
Cached News: